Analyst consensus rating
Insulet Analyst Rating: Buy
Direct answer
Insulet's consensus rating is Buy.
23 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $167.17.
Forecast evidence checked October 19, 2026.
Get free Insulet email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $141.10
- Average price target
- $167.17
- High price target
- $215.00
- Low price target
- $143.00
- Low target gap
- +1.3%
- Target upside
- +18.5%
- High target gap
- +52.4%
- Target range width
- 51%
- Consensus rating
- Buy
- Analysts
- 23
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Insulet?
Insulet has a verified Buy consensus. The same dataset has an average price target of $167.17.
How far are Insulet's low and high targets from the recorded price?
The low target implies +1.3%, while the high target implies +52.4%.
How many analysts are included in Insulet's consensus?
The verified consensus includes 23 analysts.
How is Insulet's target upside or downside calculated?
The average target of $167.17 is divided by the recorded price of $141.10, then one is subtracted to produce +18.5%. This does not guarantee a future return.
When was Insulet's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.